(ATHA) Alert: Did You Acquire Athira Before November 2020? Should Management be Held Accountable for Investors Losses? Contact Johnson Fistel

[ASFN Admin]

SAN DIEGO, Oct. 23, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP is investigating potential claims on behalf of Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA) against certain of its officers and directors. Recently a class action lawsuit was filed in federal court against the Company on behalf of purchasers of the securities of Athira from September 18, 2020 and June 17, 2021 (the "Class Period"). The Athira Pharma class-action lawsuit alleges that, throughout the Class Period, d

Continue reading...